BackBioNexus Gene Lab Overview

BioNexus Gene Lab Other Liabilities

Track BioNexus Gene Lab's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

BioNexus Gene Lab Other Liabilities History

Loading

BioNexus Gene Lab vs. peers: Other Liabilities Comparison

Loading

BioNexus Gene Lab Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioNexus Gene Lab (BGLC) FAQ

As of the most recent data (March 2026), BGLC shows a other liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BGLC's other liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether BioNexus Gene Lab is outperforming or lagging.

Tracking BGLC's other liabilities over time shows whether BioNexus Gene Lab is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has BioNexus Gene Lab's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.